EULAR 2026 and Green Congress
EULAR is Europe's largest rheumatology congress and currently brings together researchers, clinicians, other healthcare professionals and patient representatives from all over the world. You can get the international highlights from the congress by registering for the Green Congress.
This year, EULAR will be held in London, from 3 to 6 June. The congress is about new knowledge about rheumatic and musculoskeletal diseases - from basic research and new treatment options to rehabilitation, digital follow-up, patient communication and how research can be used in clinical practice. The committee expects to gather as many people as last year, when the congress had 13,542 registrations from 127 countries.
Even if you are not present, you will be able to get acquainted with important research from the congress, completely free of charge, if you register for the Green Congress digitally. The event will be held in Norwegian. It is suitable for anyone with a special interest in rheumatology and musculoskeletal diseases.
This year's EULAR program features a number of Norwegian contributions.
In this article, you will find a selection of program items that show the breadth of Norwegian rheumatological research and professional development – from systemic sclerosis, hand osteoarthritis and pediatric rheumatology to digital health, patient communication, training and follow-up of patients with rheumatic disease.
Rheumatologist Jens Vikse has highlighted a selection, which is built on here. Below the description of the selection, you will find an overview of the Norwegian contributions, around 40 of which come from the REMEDY community.
Don't forget to register for Grønn kongress to get the digital link to the streaming of the event!
Wednesday
- Home-Based Monitoring of Cardiopulmonary Complications in Systemic Sclerosis
Hilde Jenssen Bjørkekjær, PhD student in the Nor-FIORD group at OUS, presents a pilot study on home-based monitoring of cardiopulmonary manifestations in systemic sclerosis. She has worked in particular with pulmonary arterial hypertension. - Self-managing hand osteoarthritis is in the palm of your hand: the Happy Hands app
Anne Therese Tveter presents the Happy Hands project together with Ingvild Kjeken. The project has developed an app with quality-assured advice and exercises for people with hand osteoarthritis. What are the experiences? - Health literacy needs of patients with migrant backgrounds and inflammatory rheumatic diseases
Laura Treacy presents a study on the health literacy needs of patients with migrant backgrounds. How can language, culture and access to information affect patients' ability to understand the disease, use health services and actively participate in their own treatment? - Foundations of successful communication in clinic
Anna Fryxelius gives an invited talk about the importance of communication between therapist and patient. With experience as a patient, patient representative and specialist manager in the Norwegian Rheumatology Association, she shows how communication in the clinic can influence treatment, collaboration and compliance.
Thursday
- Juvenile Idiopathic Arthritis
- PhD students Imane Barden and Alexander Nima Sharami present long-term outcomes in juvenile idiopathic arthritis and remission data from minJIA, respectively.
- The RheumaVision research knowledge transfer contest
Vilde Øverlien Dåstøl, PhD fellow in the Prevent-JIA study, represents Norway in the final of EULAR's RheumaVision communication competition. She shows how the question "did Vikings have RA?" can teach us more about research methodology and risk factors for disease development. - How do the new EULAR/ERS guidelines impact therapeutic management of CTD-ILD and RA-ILD?
Anna Hoffmann-Vold, one of the leading experts in CTD-ILD and the latest author of the ERS/EULAR recommendations in the field, will give two presentations. She will discuss both how the recommendations may impact the treatment of RA-ILD, and other clinical implications of the guideline.
Friday
- Results from the 5-year NOR-Gout study
Hilde Berner Hammer presents findings from the NOR-Gout study. The study shows a correlation between crystal deposits and erosions. The presentation will be one of the highlights for anyone interested in ultrasound in rheumatology.
- Patient-initiated follow-up is more cost-effective than remote monitoring or usual care in axial spondyloarthritis
Inger Jorid Berg, postdoctoral fellow in the ReMonit study, presents data on the cost-effectiveness of patient-initiated follow-up. This is compared with digital follow-up and usual care of patients with axial spondyloarthritis.
Saturday
- Results from part 2 of the randomized NORD-STAR trial
Marte Schrumpf Heiberg presents data on bDMARD tapering in RA patients in remission. This is a clinically important topic in discussions with patients considering reduced treatment. - 10-year follow-up of the ARCTIC trial
Henrik Mangseth presents data on prevalence and risk factors for RA-ILD from ARCTIC forward. Lena Bugge Nordberg presents other 10-year data from the same cohort. - Impact of TNF-inhibitor discontinuation on postpartum flare in rheumatoid arthritis
Ingunn Sagberg presents results from RevNatus on flare-ups of RA after a break in treatment with TNF-inhibitors. - Rheumatology in the digital health era
Nina Østerås gives an invited talk about how digital solutions can change follow-up, treatment and interaction – and what it takes for the technology to actually benefit patients and healthcare professionals.
Program - Norwegian contributions
WEDNESDAY, June 3, 2026
- 14:15-15:30 Clinical Science • N2
Ragnar Gunnarsson The enigma of mixed connective tissue disease in challenging the rheumatologist clinical care - 14:35-14:50 Invited Speaker Presentation • Victoria Room 1
Rikke Helene Moe What is what we are trying to move forward when implementing our strategic action points in practice - 15:30-16:30 Poster View Presentations • Poster View
Hilde Jenssen Bjørkekjær The Nor-SSCardioCare Open-Label Clinical Pilot Trial: Home-Based Monitoring of Cardiopulmonary Complications in Systemic Sclerosis - 15:30-16:30 Poster View Presentations • Poster View
Gunhild Hagen Cost-effectiveness of pneumococcal vaccination in 50-year-old patients with rheumatoid arthritis in Norway-A Markov modeling analysis - 15:30-16:30 Poster View Presentations • Poster View
Kristine Norden Reporting of exercise interventions in spondyloarthritis research: A systematic review of randomized controlled trials - 15:30-16:30 Poster View Presentations • Poster View
Abdirizak Ali Osman Associations between physical activity and body composition in individuals with psoriatic arthritis - longitudinal observations in the Trøndelag Health Study - 15:30-16:30 Poster View Presentations • Poster View
Linde Steenvoorden MRI-detected axial inflammation in newly diagnosed psoriatic arthritis - 15:30-16:30 Poster View Presentations • Poster View
Stig Tengesdal Lifetime Risk of Malignancy in Polymyalgia Rheumatica: A Population-Based Matched Cohort Study from Southern Norway - 16:06-16:12 Poster Tour Presentations • PARE Poster Tour
Anna Fryxelius Making Sense of Fibromyalgia: Developing an Expert-Led Digital Learning Program for Patients - 16:18-16:24 Poster Tour Presentations • Poster Tour III
Gunhild Hagen Cost-effectiveness of herpes zoster vaccination in patients with rheumatoid arthritis - 16:30-16:45 Invited Speaker Presentation • Victoria Room 2
Anna Fryxelius Foundations of successful communication in clinic - 16:40-16:50 Oral Abstract Presentation • Victoria Room 1
Laura Treacy Health literacy needs of patients with migrant backgrounds and inflammatory rheumatic diseases - a qualitative exploration - 16:40-16:45 Invited Speaker Presentation • George V Room 3
Anne Therese Tveter Self-managing hand osteoarthritis is in the palm of your hand: the Happy Hands app
THURSDAY, June 4, 2026
- 08:15-08:25 Oral Abstract Presentations • George V Room 2
Ingunn Sagberg Disease activity during and after pregnancy in women with rheumatoid arthritis: a prospective multientre study from Norway - 08:35-08:45 Oral Abstract Presentations • Connaught 1&2
Imane Barden Long-term Outcomes of Juvenile Idiopathic Arthritis in Adulthood: a Population-Based Matched Comparator Study from Norway - 08:55-09:05 Oral Abstract Presentations • Connaught 1&2
Alexander Nima Sharami Components of JIA-ACR (Wallace) inactive disease criteria after initiation of TNF inhibitors: Results from the MyJIA trial - 09:05-09:15 Oral Abstract Presentations • Victoria Room 1
Mari Nilsen Skinnes Work participation trajectories before and after multidisciplinary rehabilitation across occupational groups in people with RMDs: a multicentre cohort study - 09:15-09:25 Oral Abstract Presentations • Victoria Room 2
Ingeborg Dybvig Chronic Competence - see the resources, not the restrictions - 09:30-10:30 Poster Tour Presentations • Poster Tour
Christine Hestevik Experiences with high-intensity training among patients with inflammatory disease - 09:48-09:54 Poster Tour Presentations • Poster Tour II
Anna-Maria Hoffmann-Vold Risk factors for interstitial lung disease in rheumatoid arthritis - 11:20-11:45 Invited Speaker Presentation • N3
Anna-Maria Hoffmann-Vold How do the new EULAR/ERS guidelines impact therapeutic management of RA-ILD? - 13:30-14:30 Poster Tour Presentations • Poster View
Miss Eli J. Platou Sollerud The Benefit of Carotid Ultrasound in Patients with Inflammatory Joint Diseases - 14:00-14:06 Poster Tour Presentations • Poster Tour
Julie Hillesland Osteoporosis in Norway: Increasing Access to Safe and Evidence-Based Exercise Program - 14:45-16:00 Chair • Victoria Room 1
Tuva Moseng Please mind the gap: Approaches to Implementing Research into Rheumatology Practice - 15:05-15:25 Invited Speaker Presentation • George V Room 3
Anna-Maria Hoffmann-Vold From Guidelines to Clinical Practice: Clinical Implications of the 2025 ERS/EULAR guidelines of CTD-ILD - 15:14-15:22 EMEUNET Presents • George V Room 1
Vilde Øverlien Dåstøl The RheumaVision research knowledge transfer contest - 16:15-17:30 Hands-on Sessions • Hands-on 2
Hilde Berner Hammer Fast ultrasound protocols in Rheumatology: Point of Care - 16:24-16:30 Poster Tour Presentations • Poster Tour V
Gunhild Hagen Cost-effectiveness of a high-intensity exercise program for axial spondyloarthritis: a modeling study - 16:40-17:30 Hands-on Sessions • Hands-on 2
Hilde Berner Hammer Hands-on Workshops
FRIDAY, June 5, 2026
- 08:45-08:55 Oral Abstract Presentations • N2
Hilde Berner Hammer Presence of crystal deposits in the first metatarsophalangeal joint is closely related to local erosions; results from the 5-year NOR-Gout study - 09:30-09:30 Poster View Presentations • Poster View
Inger Jorid Berg Patient-initiated follow-up is more cost-effective than remote monitoring or usual care in axial spondyloarthritis, results from the ReMonit randomized controlled trial - 10:30-11:15 Chair • Plenary
Ida K. Haugen Osteoarthritis - 10:30-11:45 Hands-on Session • Hands-on 1
Hilde Berner Hammer Fast ultrasound protocols in Rheumatology: Point of Care - 10:50-10:55 Hands-on Session • Hands-on 1
Hilde Berner Hammer Questions and Answers - 10:55-11:35 Hands-on Session • Hands-on 1
Hilde Berner Hammer Hands-on Stations - 13:30-14:45 Hands-on Session • Hands-on 1
Hilde Berner Hammer Fast ultrasound protocols in Rheumatology: Point of Care - 13:50-13:55 Hands-on Session • Hands-on 1
Hilde Berner Hammer Questions and Answers - 13:55-14:45 Hands-on Session • Hands-on 1
Hilde Berner Hammer Hands-on Workshop - 13:48-13:54 Poster View Presentations • Poster Tour III
Joachim Sagen Supporting Sustainable Work Participation Among Young Adults with Rheumatic and Musculoskeletal Diseases: A Patient-Led Initiative Aligned with Inclusive Working Life Policies - 14:45-16:30 Chair • Plenary
Helena Andersson Idiopathic Inflammatory Myopathies - 16:00-16:00 Poster View Presentations • Poster View
Kristine Løkås Haftorn Evidence for Shared Genetic Risk between Infertility and Juvenile Idiopathic Arthritis: Results from Population-Based Pregnancy Cohorts - 16:00-16:00 Poster View Presentations • Poster View
Kjersti Johnsrud 68Ga-DOTATOC PET/CT in systemic sclerosis: preliminary data from a prospective, single-centre pilot study - 16:00-16:00 Poster View Presentations • Poster View
Ingrid Herder Disease activity according to adalimumab serum levels in Juvenile Idiopathic Arthritis: Results from the My-JIA trial - 16:00-16:00 Poster View Presentations • Poster View
Vilde Øverlien Dåstøl Maternal Weight Gain and Hypertensive Disorders of Pregnancy as Risk Factors for Juvenile Idiopathic Arthritis: A Prospective Population-Based Pregnancy Cohort Study - 16:00-16:00 Poster View Presentations • Poster View
Vilde Øverlien Dåstøl Exposure to Harmful Substances during Pregnancy, Gene-Environment Interactions and Risk of Juvenile Idiopathic Arthritis (JIA): An Exploratory Analysis from The Norwegian Mother, Father and Child Cohort Study - 16:00-16:00 Poster View Presentations • Poster View
Ingrid Nordmo A patient education app and a clinical decision support system for people with knee osteoarthritis: the OA-AID feasibility study - 16:00-16:00 Poster View Presentations • Poster View
Sigrid Valen Hestetun Early-Life Infections, Antibiotics and Gene-Environment Interactions in the Risk of Juvenile Idiopathic Arthritis: Evidence from two Scandinavian Birth Cohorts - 16:27-16:33 Poster Tour Presentations • Poster Tour V
Karolina Lendowska Changes in ultrasound findings of synovitis during TNF⍺ inhibitor treatment in children with Juvenile Idiopathic Arthritis. Results from the My-JIA Trial - 16:33-16:39 Poster Tour Presentations • Poster Tour V
Mrs Srijana Bastakoti Genetic Architecture of Juvenile Idiopathic Arthritis from a Large-Scale Genome-Wide Association Study Meta-Analysis - 16:51-16:57 Poster Tour Presentations • Poster Tour IV
Anna-Maria Hoffmann Vold A Phase III, Double-blind, Randomised, Placebo-controlled Trial Evaluating the Safety and Efficacy of Oral Nerandomilast Treatment on Halting Disease Progression in Systemic Sclerosis - 16:51-16:57 Poster Tour Presentations • Poster Tour I
Anne-Lene Sand-Svartrud Pain severity matters in long-term rehabilitation trajectories of function and quality of life.
SATURDAY, June 6, 2026
- 09:00-09:15 Invited Speaker Presentation • Victoria Room 1
Rikke Helene Moe Educate, empower, engage: A holistic strategy for better mental health - 09:00-10:15 Chair • N1
Lilliann Wermskog From Pain to Progress: Encouraging Exercise and Healthy Living in AxSpA - 09:00-10:15 Chair • Victoria Room 4
Tore K. Kvien Advancing Global Health in Rheumatology: Building Capacity, Equity, and Resilience Across Borders - 10:15-10:15 Poster View Presentations • Poster View
Anna-Maria Hoffmann-Vold Safety and tolerability of nerandomilast in patients with autoimmune disease–related progressive pulmonary fibrosis in the FIBRONEER-ILD trial - 10:15-10:15 Poster View Presentations • Poster View
Anna-Maria Hoffmann-Vold Nebulized pirfenidone (AP01) for progressive pulmonary fibrosis in connective tissue disease-associated and other interstitial lung diseases: 4-year data from the ATLAS open label extension trial - 10:15-10:15 Poster View Presentations • Poster View
Marte S. Heiberg Early versus late dose reduction of biological treatment in RA patients in stable remission: Results from part 2 of the randomized NORD-STAR trial - 10:15-10:15 Poster View Presentations • Poster View
Eirik Ikdahl Norwegian Quality Assurance Audit - 10:15-10:15 Poster View Presentations • Poster View
Henrik Mangseth Prevalence and risk factors for interstitial lung disease in patients with rheumatoid arthritis receiving treat-to-target therapy from disease onset: 10-year follow-up of the ARCTIC trial - 10:15-10:15 Poster View Presentations • Poster View
Henrik Mangseth Prevalence of bronchiectasis, emphysema and airflow obstruction in established rheumatoid arthritis patients receiving modern treatment from disease onset - 10:15-10:15 Poster View Presentations • Poster View
Ingrid Rekaa Nilssen Mental Health and Quality of Life During Pregnancy and Postpartum in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Results from the Norwegian RevNatus Registry - 10:15-10:15 Poster View Presentations • Poster View
Lena Nordberg Long-term outcomes in patients with rheumatoid arthritis treated according to treat-to-target recommendations: 10-year follow-up of the ARCTIC trial - 10:15-10:15 Poster View Presentations • Poster View
Ingunn Sagberg Impact of TNF-inhibitor discontinuation on postpartum flare in rheumatoid arthritis: results from the Norwegian RevNatus Registry - 10:30-11:45 Chair • Victoria Room 1
Heidi Zangi Redefining patient education: linking knowledge, adherence and change - 10:33-10:39 Poster View Presentations • Poster Tour I
Marthe Mæhlen Patient-Reported Health Status Is Associated with Mortality in Early Systemic Sclerosis Across Key Disease Charateristics: Data from the Norwegian “NOSVAR” Registry - 11:03-11:09 Poster View Presentations • Poster Tour V
Anna-Maria Hoffmann-Vold Efficacy of nerandomilast in patients with autoimmune interstitial lung diseases and progressive pulmonary fibrosis in the FIBRONEER-ILD trial - 12:00-13:15 Chair • Victoria Room 1
Kristine Norden Muscle Matters: Advancing Care Through Targeted Muscle Fitness - 12:05-12:25 Invited Speaker • George V Room 3
Nina Osteras Rheumatology in the digital health era
Welcome to the Green Congress, June 19, for important
